BNGO ▲ +1.6% - Bionano Genomics, Inc. $BNGO - Bionano Announces Three New Peer-Reviewed Studies Demonstrate Clinical Value of Bionano's Optical Genome Mapping Across Myelodysplastic Syndromes and Acute Myeloid Leukemia Bionano Genomics rose 1.6% following the announcement of three new peer-reviewed studies showing that its optical genome mapping technology has clinical value in detecting chromosomal abnormalities in myelodysplastic syndromes and acute myeloid leukemia. The publication of these studies in peer-reviewed journals strengthens the scientific evidence supporting the diagnostic utility of Bionano's core technology in hematologic malignancies. 14-SEP-2026 09:00 AM ET